Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Different Doses of Neostigmine for Reversal of Cisatracurium-induced Moderate Neuromuscular Blockade in Children Under Sevoflurane Anesthesia

NCT05053594 is registered in ClinicalTrials.gov with Pontificia Universidade Catolica de Sao Paulo as lead sponsor.

NCT NCT05053594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05053594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Different Doses of Neostigmine for Reversal of Cisatracurium-induced Moderate Neuromuscular Blockade in Children Under Sevoflurane Anesthesia
Lead sponsor
Pontificia Universidade Catolica de Sao Paulo
Phase
Phase 4
Overall status
Unknown status
Start date
October 1, 2021
Completion date
February 20, 2022
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neuromuscular block prolonged, neuromuscular block, residual, neuromuscular blockade